INHibition of the Renin Angiotensin System in Hypertrophic Cardiomyopathy and the Effect on Ventricular Hypertrophy - a Randomized Intervention Trial With Losartan.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Losartan (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Therapeutic Use
- 09 Jul 2014 Biomarkers information updated
- 10 Jun 2013 Planned end date changed from 1 Nov 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 16 Nov 2011 New source identified and integrated (European Clinical Trials Database).